Latest UCB Stories
ATLANTA, June 14 /PRNewswire/ -- Lt.
ATLANTA, June 14 /PRNewswire/ -- UCB today announced the availability of an oral solution formulation of VimpatÂ® (lacosamide) C-V, an antiepileptic drug (AED) for add-on treatment of partial-onset seizures in people with epilepsy age 17 years and older.
Improved treatment of severe epilepsy could reduce the overall cost of the condition, according to research presented at the annual meeting of the International Society of Pharmacoeconomic Outcomes Research (ISPOR) at the Hilton Atlanta in Atlanta, Georgia.
ATLANTA, May 2 /PRNewswire/ -- UCB announced today results of an open-label extension study, PRECiSE 4 (P4), of CimziaÂ® (certolizumab pegol; CZP) demonstrating that Cimzia provides sustained efficacy over four years in moderate to severe Crohn's Disease patients regardless of whether patients were previously treated with infliximab (IFX) or infliximab-naive.
ATLANTA, April 14 /PRNewswire/ -- Evidence of NeuproÂ® (Rotigotine Transdermal System) improving motor as well as non-motor symptoms of Parkinson's disease was presented at the 62nd American Academy of Neurology annual meeting in Toronto, Canada.
ATLANTA, April 9 /PRNewswire/ -- The antiepileptic drug (AED) VimpatÂ® (lacosamide) (C-V) will be the subject of numerous studies and analyses at the 62nd annual American Academy of Neurology (AAN) meeting, taking place at the Metro Toronto Convention Centre in Toronto from April 10-17. To view the multimedia assets associated with this release, please click: http://www.prnewswire.com/mnr/vimpat/34012/ "The breadth and depth of Vimpat data being presented at AAN suggests that the neurology...
ATLANTA, April 8 /PRNewswire/ -- Extensive new data on rotigotine will be presented at the 62nd American Academy of Neurology annual meeting in Toronto, Canada between April 10th and 17th, 2010. At a series of oral and poster presentations, leading international investigators will report the latest data on rotigotine in all stages of Parkinson's disease and in moderate to severe Restless Legs Syndrome (RLS). Oral presentations SP710 (5 year) Long-term Safety and Efficacy of Rotigotine in...
ATLANTA, March 5 /PRNewswire/ -- Applications are being accepted until March 19, 2010 for the UCB Rheumatoid Arthritis Family Scholarship. These scholarships are for rheumatoid arthritis patients or their immediate family members.
DALLAS, January 28 /PRNewswire/ -- Now in its 9th year, the ePharma Summit (http://www.epharmasummit.com), to be held this year at the Hyatt Regency at Penn's Landing, Philadelphia, PA ,continues to be the most innovative digital marketing event for the pharmaceutical sector.
February 25-26 Forum to Bring Together Innovators, Clinicians and Investors MIDDLEBURG, Va., Jan.
- To give a box on the ear to.